|
⚲
|
| Keyboard |
| Natasha Giordano | |
|---|---|
| Firm | |
| Address | 701 E Bay Street Suite 402 Charleston, SC 29403 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Afaxys Inc | 021-551638 | Director | of 5.0 M |
||
| Matinas Biopharma Holdings Inc | 021-538675 | Director | 1.6 M of 3.3 M |
||
| PLX Pharma Inc | 021-381708 | Executive Officer | 18.0 M of 18.0 M |
||
| PLX Pharma Inc | 021-367889 | Executive Officer | 8.0 M of 8.0 M |
||
| PLX Pharma Inc | 021-333941 | Executive Officer | 15.0 M of 15.0 M |
||
| PLX Pharma Inc | 021-289624 | Executive Officer | 18.2 M of 18.2 M |
||
| PLX Pharma Inc | 021-259059 | Executive Officer | 1.3 M of 2.0 M |
||
| Healthcare Corp of America | 021-219788 | Executive Officer | 3.2 M of 3.2 M |
||
| ClearPoint Learning Systems Inc | 021-180625 | Director | 0.5 M of 0.5 M |
||
| Xanodyne Pharmaceuticals Inc | 021-79890 | Executive Officer | 87.8 M of 87.8 M |
||